Current childhood chronic myeloid leukemia management under tyrosine kinase inhibitor treatment.

Autor: Karadaş N; Pediatric Hematology Department, Ege University School of Medicine, Bornova, Izmir, Turkey. drnihalozdemir@yahoo.com.; Department of Pediatric Hematology, Children's Hospital, Izmir, Turkey. drnihalozdemir@yahoo.com., Göktepe ŞŞÖ; Pediatric Hematology Department, Ege University School of Medicine, Bornova, Izmir, Turkey., Baş İ; Pediatric Hematology Department, Ege University School of Medicine, Bornova, Izmir, Turkey., Ece D; Pediatric Hematology Department, Ege University School of Medicine, Bornova, Izmir, Turkey., Özdemir HH; Pediatric Hematology Department, Ege University School of Medicine, Bornova, Izmir, Turkey., Balkan C; Department of Pediatric Hematology, Children's Hospital, Izmir, Turkey., Kavaklı K; Department of Pediatric Hematology, Children's Hospital, Izmir, Turkey., Aydinok Y; Department of Pediatric Hematology, Children's Hospital, Izmir, Turkey., Karapinar DY; Department of Pediatric Hematology, Children's Hospital, Izmir, Turkey.

Publikováno v: International journal of hematology [Int J Hematol] 2023 Mar; Vol. 117 (3), pp. 446-455. Date of Electronic Publication: 2022 Nov 19.